Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of Type 2 diabetes

Details for Australian Patent Application No. 2003302279 (hide)

International Classifications

Event Publications

15 July 2004 Complete Application Filed

Priority application(s): 60/415,860 03.10.02 US

29 July 2004 Application Open to Public Inspection

Published as AU-B-2003302279

12 June 2008 Application Accepted

Published as AU-B-2003302279

9 October 2008 Standard Patent Sealed

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.